Henry Schein (NASDAQ:HSIC) Announces Quarterly Earnings Results

Henry Schein (NASDAQ:HSIC) released its quarterly earnings data on Tuesday. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04), Zacks reports. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. During the same period last year, the company earned $0.66 earnings per share. The firm’s revenue was up 5.8% on a year-over-year basis. Henry Schein updated its FY 2025 guidance to 4.800-4.940 EPS and its FY25 guidance to $4.80-4.94 EPS.

Henry Schein Price Performance

Shares of Henry Schein stock opened at $77.64 on Tuesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The business has a 50 day simple moving average of $74.19 and a two-hundred day simple moving average of $72.38. The stock has a market capitalization of $9.68 billion, a P/E ratio of 31.95, a PEG ratio of 2.13 and a beta of 0.91. Henry Schein has a 12 month low of $63.67 and a 12 month high of $82.63.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Barrington Research upped their price target on shares of Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a report on Thursday, January 30th. Mizuho assumed coverage on Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price on the stock. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Wells Fargo & Company started coverage on shares of Henry Schein in a research note on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective on the stock. Finally, Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and lifted their target price for the company from $69.00 to $84.00 in a report on Monday, January 6th. Eight research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $80.09.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.